Oklahoma · 2026
HB 3834
Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights; reports; intellectual property account; effective date.
Bill record: Open States bulk CSV (bills/votes) CC0-1.0
Issue tags AI-classified
Classified by a local model from the bill's text; confidence shown. GovTally LLM enrichment (local oMLX)
Sponsors
- Avery Frix Republican lead
- Stan May Republican lead
Roll-call votes on this bill
| Question | Chamber | Result | Yea | Nay | Other | Date | Source |
|---|---|---|---|---|---|---|---|
| Fourth Reading | lower | pass | 68 | 21 | 9 | May 6, 2026 | Open States bulk CSV (bills/votes) CC0-1.0 |
| Third Reading | upper | pass | 33 | 9 | 6 | Apr 29, 2026 | Open States bulk CSV (bills/votes) CC0-1.0 |
| Appropriations | upper | pass | 20 | 0 | 0 | Apr 22, 2026 | Open States bulk CSV (bills/votes) CC0-1.0 |
| Health & Human Services | upper | pass | 10 | 2 | 0 | Apr 13, 2026 | Open States bulk CSV (bills/votes) CC0-1.0 |
| Third Reading | lower | pass | 67 | 23 | 8 | Mar 11, 2026 | Open States bulk CSV (bills/votes) CC0-1.0 |
| Health And Human Services Oversight Committee: Do Pass | lower | pass | 10 | 0 | 0 | Feb 19, 2026 | Open States bulk CSV (bills/votes) CC0-1.0 |
| Public Health Committee: Do Pass | lower | pass | 5 | 0 | 0 | Feb 11, 2026 | Open States bulk CSV (bills/votes) CC0-1.0 |